In Q220, all geographies experienced shrinkage in their AWC revenues with Single-use NPWT showing the sharpest declines.
All companies are experiencing a negative impact on their wound businesses from COVID-19 in Q220, but most are also stating that June was better than April, indicating a strong recovery in the wound market. 3M* remains the WW market leader with Q220 revenue down -14.9% YoY. WW Advanced Dressings declined -9.9%, impacted by COVID-19, especially in hospitals. US Skin/Dermal Substitute (CTP) revenue fell also, with mixed results from market leaders. WW NPWT was down -17.8%, with single-use and traditional devices down -24.2% and -16.4%, respectively.
Among the many topics covered in the comprehensive Q220 Advanced Wound Care Market Recap* are:
- Complete Market Overview with Company Revenues and Shares
- Impact of COVID-19 on Q220 Market Leaders
- Wound Biologics – Mixed Results
- NPWT – COVID-19 Creates Negative Pressure on NPWT Devices
- Advanced Dressings – Limited COVID-19 Impact
- Detailed Growth Analysis
- Q220 Growth in Constant and Reported in Key Companies
- Other Notable Happenings in Q220 AWC Market
All companies tracked showed negative organic growth in the quarter. Smith+Nephew* saw the greatest impact, with its business largely focused on hospitals. Coloplast and Mölnlycke performed better, with businesses more focused on home care, especially in Europe. Hartmann* declined as their traditional wound range was ...
Read the entire Q220 Advanced Wound Care Market Recap including news, data, charts, company revenues and analysis*
*The entire article and the links can only be viewed by SmartTRAK subscribers to this module. For more information on how to receive a demo and subscribe, please click the button below.